December 22, 2023
- October 30, 2023 - BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed) See Announcement RFA-NS-24-028
- February 22, 2022 - BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) See Announcement RFA-NS-22-049
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this Notice is to inform applicants of a change to the Application and Submission Information - Post Submission Materials allowed for the following announcements:
RFA-NS-24-028 BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
RFA-NS-22-049 BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
The notices of funding opportunity (NOFOs) have been modified to allow one-page of preliminary data as a post-submission material. This notice is effective for all remaining receipt dates. Changes to the NOFOs are shown below.
Currently Reads:
Section IV. Application and Submission Information
7. Other Submission Requirements and Information
Post Submission Materials
Applicants are required to follow the instructions for post-submission materials, as described in the policy
Modified to Read:
Section IV. Application and Submission Information
7. Other Submission Requirements and Information
Post Submission Materials
Applicants are required to follow the instructions for post-submission materials, as described in the policy. This NOFO will accept a one-page update with preliminary data as post-submission materials.
The deadline for submitting all post-submission materials, including preliminary data, will be 30 days before the study section meeting.
All other materials listed in NOT-OD-19-083 as acceptable post-submission materials will continue to be accepted if submitted 30 days before the study section meeting.
All other aspects of the NOFOs remain unchanged.
Kari Johnson, PhD
Edmund Talley, PhD
National Institute of Neurological Disorders and Stroke
and Human Services (HHS)
